Nurtured by numerous infectious diseases’ outbreaks, the world disinfectant and antiseptic market is expected to reach US$7 billion by 2016, about double its present size. companiesandmarkets.com
In 2009, the global disinfectant and antiseptic market was worth some US$3.4 billion, but by 2010 had grown more than 12%, to reach a value of US$3.8 billion, according to a new report available from companiesandmarkets.com.
‘Market growth has accelerated in recent years following large scale outbreaks of several infectious diseases, such as MRSA, avian and swine flu,’ noted the release.
The US, which constituted about 41% (US$1.5 billion) of the total antiseptics and disinfectants market in 2010, is expected to increase to nearly US$2.9 billion by 2016 at a compound annual growth rate of 11%. Europe contributed to about 34% of the total market and was US$1.3 billion in 2010 and has reached US$1.4 billion in 2011. The European market is expected to grow at a CAGR of 11.2% and reach US$2.4 billion by 2016.
‘The last decade has seen a rise in the incidence of infectious diseases, and recent outbreaks of swine flu and avian flu have triggered market growth for disinfectants and antiseptic products. These occurrences have heightened public understanding of the serious potential dangers of infection, and the global media coverage which accompanied these incidents has also amplified awareness,’ noted the companiesandmarkets.com report.
The global antiseptic and disinfectant research report contains 134 pages of insightful market information, with forecast and historical data for the period 2009-2016. The antiseptic market and the disinfectant market are discussed at length, incorporating analysis of key players; existing and future development strategies; products and their modes of action; innovation; patents; trends; M&A/collaborations; growth barriers/drivers; regulations, and other influencing factors.